The purpose of the Protocol Review and Monitoring System (PRMS) is to review the scientific merit,scientific priorities, and scientific progress of cancer-related studies that are conducted at the Universityof Chicago and that use UCCRC resources. The UCCRC PRMS is divided into two committees, theClinical Trials Review Committee (CTRC), and the Scientific and Accrual Monitoring Committee (SAM),which are overseen by the Associate Director for Clinical Sciences (Dr. Mark Ratain) and the ClinicalResearch Advisory Committee (CRAC). A single Coordinator serves all three committees. The CTRCand SAM are composed of UCCRC members from all academic units and disciplines who haveexpertise in clinical trials. The CTRC meets monthly, and has primary responsibility for evaluation of thescientific merit, rigor, appropriateness of data and safety monitoring, and the relative prioritization oftrials in the context of UCCRC goals and resources. CTRC and IRB review occur simultaneously, butprotocol activation requires full CTRC approval. CTRC reviews are conducted by at least 3 individuals,including a biostatistician. Protocols may be approved, approved with revisions, deferred, ordisapproved. Protocols that have undergone prior peer review (e.g., cooperative group protocols, NIH,ACS) are eligible for expedited review; that is, they are not required to be reviewed by the fullcommittee, but rather will be reviewed by the Chair or Co-chair who have the option of bringing them tothe full committee if there are specific concerns (e.g., design, prioritization). The SAM has primaryresponsibility for monitoring the scientific progress of CTRC-approved studies including accrual, minorityaccrual, overall progress towards meeting the study's objectives, as well as ensuring adherence toprotocol procedures and UCCRC Data and Safety Monitoring requirements. The SAM meets monthly,and has the authority to close protocols that are not making adequate scientific progress, or that are notmeeting adequate scientific or Data and Safety Monitoring guidelines.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014599-33
Application #
7714299
Study Section
Special Emphasis Panel (ZCA1-RTRB-N (J1))
Project Start
2008-07-22
Project End
2013-03-31
Budget Start
2008-07-22
Budget End
2009-03-31
Support Year
33
Fiscal Year
2008
Total Cost
$75,378
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Szmulewitz, Russell Z; Peer, Cody J; Ibraheem, Abiola et al. (2018) Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer. J Clin Oncol 36:1389-1395
Boisclair Lachance, Jean-François; Webber, Jemma L; Hong, Lu et al. (2018) Cooperative recruitment of Yan via a high-affinity ETS supersite organizes repression to confer specificity and robustness to cardiac cell fate specification. Genes Dev 32:389-401
Kudron, Michelle M; Victorsen, Alec; Gevirtzman, Louis et al. (2018) The ModERN Resource: Genome-Wide Binding Profiles for Hundreds of Drosophila and Caenorhabditis elegans Transcription Factors. Genetics 208:937-949
Maron, Steven B; Alpert, Lindsay; Kwak, Heewon A et al. (2018) Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGFR-Amplified Gastroesophageal Adenocarcinoma. Cancer Discov 8:696-713
Kane, Melissa; Deiss, Felicity; Chervonsky, Alexander et al. (2018) A Single Locus Controls Interferon Gamma-Independent Antiretroviral Neutralizing Antibody Responses. J Virol 92:
Zeineddine, Hussein A; Girard, Romuald; Saadat, Laleh et al. (2018) Phenotypic characterization of murine models of cerebral cavernous malformations. Lab Invest :
Gamazon, Eric R; Trendowski, Matthew R; Wen, Yujia et al. (2018) Gene and MicroRNA Perturbations of Cellular Response to Pemetrexed Implicate Biological Networks and Enable Imputation of Response in Lung Adenocarcinoma. Sci Rep 8:733
Xiao, Annie; Crosby, Jennie; Malin, Martha et al. (2018) Single-institution report of setup margins of voluntary deep-inspiration breath-hold (DIBH) whole breast radiotherapy implemented with real-time surface imaging. J Appl Clin Med Phys 19:205-213
Day, Kasey J; Casler, Jason C; Glick, Benjamin S (2018) Budding Yeast Has a Minimal Endomembrane System. Dev Cell 44:56-72.e4
Girard, Romuald; Zeineddine, Hussein A; Koskimäki, Janne et al. (2018) Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth. Circ Res 122:1716-1721

Showing the most recent 10 out of 668 publications